CollPlant Biotechnologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by CollPlant Biotechnologies Ltd. on August 8, 2019, covering events occurring in August 2019. The registrant is a foreign private issuer based in Rehovot, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements.
Material Changes
- Leadership Change: On August 6, 2019, the Company terminated the Chairman Services Agreement with Jonathan Rigby, effective immediately.
- Board Status: Mr. Rigby ceased to serve as Chairman of the Board but continues to serve as a director of the Company.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items beyond the disclosed termination of the Chairman Services Agreement.
Key Facts for Investor Verification
- Verify the current composition of the Board of Directors following Mr. Rigby's removal as Chairman.
- Confirm if a new Chairman has been appointed or if the role remains vacant.
- Review subsequent filings for any financial updates, as this 6-K contains no financial data.